Log In
BCIQ
Print this Print this
 

MRG-106

  Manage Alerts
Collapse Summary General Information
Company miRagen Therapeutics Inc.
DescriptionSynthetic microRNA antagonist of miR-155
Molecular Target MicroRNA-155 (miR-155)
Mechanism of ActionMicroRNA-155 (miR-155) antagonist
Therapeutic ModalityNucleic acid: Linear RNA: microRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today